For: | Alkagiet S, Papagiannis A, Tziomalos K. Associations between nonalcoholic fatty liver disease and ischemic stroke. World J Hepatol 2018; 10(7): 474-478 [PMID: 30079133 DOI: 10.4254/wjh.v10.i7.474] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v10/i7/474.htm |
Number | Citing Articles |
1 |
Amine Benmassaoud, Marc Deschenes, Tianyan Chen, Peter Ghali, Giada Sebastiani. Optimizing patients with non-alcoholic fatty liver disease pre-transplant. Canadian Liver Journal 2020; 3(3): 237 doi: 10.3138/canlivj-2019-0025
|
2 |
Yun-Jung Yang, Mi-Hyang Jung, Seok-Hoo Jeong, Yeon-Pyo Hong, Yeong In Kim, Sang Joon An. The Association between Nonalcoholic Fatty Liver Disease and Stroke: Results from the Korean Genome and Epidemiology Study (KoGES). International Journal of Environmental Research and Public Health 2020; 17(24): 9568 doi: 10.3390/ijerph17249568
|
3 |
Meng Wang, Ben-Gang Zhou, Yi Zhang, Xi-Fang Ren, Ling Li, Bo Li, Yao-Wei Ai. Association Between Non-alcoholic Fatty Liver Disease and Risk of Stroke: A Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.812030
|
4 |
Hayatul Najaa Miptah, Anis Safura Ramli, Mariam Mohamad, Hilwati Hashim, Zahirah Tharek. Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association?. BMC Family Practice 2020; 21(1) doi: 10.1186/s12875-020-01306-7
|
5 |
Friedrich Horn, Till Ittermann, Marie-Luise Kromrey, Danilo Seppelt, Henry Völzke, Jens-Peter Kühn, Felix Schön. Exploring factors associated with non-alcoholic fatty liver disease using longitudinal MRI. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03300-0
|
6 |
Jorge Gutiérrez-Cuevas, Arturo Santos, Juan Armendariz-Borunda. Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases. International Journal of Molecular Sciences 2021; 22(21): 11629 doi: 10.3390/ijms222111629
|
7 |
James Woijoo Kim, Giada Sebastiani. Hidden Complication of Obesity and Diabetes: Is It Time to Put More Focus on Fatty Liver?. EMJ Diabetes 2023; : 77 doi: 10.33590/emjdiabet/10307262
|
8 |
Minyoul Baik, Seung Up Kim, Hyo Suk Nam, Ji Hoe Heo, Young Dae Kim. The Paradoxical Protective Effect of Liver Steatosis on Severity and Functional Outcome of Ischemic Stroke. Frontiers in Neurology 2019; 10 doi: 10.3389/fneur.2019.00375
|
9 |
Andrea Boccatonda, Lorenzo Andreetto, Damiano D’Ardes, Giulio Cocco, Ilaria Rossi, Susanna Vicari, Cosima Schiavone, Francesco Cipollone, Maria Teresa Guagnano. From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications. Biomedicines 2023; 11(3): 883 doi: 10.3390/biomedicines11030883
|
10 |
Ya-Juan Zhang, Wen-Juan Liu. Association between non-alcoholic fatty liver and acute cerebral infarction: a protocol of systematic review and meta-analysis. Medicine 2020; 99(24): e20351 doi: 10.1097/MD.0000000000020351
|
11 |
Naoto Hashimoto, Manabu Wakagi, Katsunari Ippoushi, Yuko Takano-Ishikawa. Involvement of the hepatic branch of the vagus nerve in the regulation of plasma adipokine levels in rats fed a high-fructose diet. The Journal of Nutritional Biochemistry 2019; 71: 90 doi: 10.1016/j.jnutbio.2019.06.003
|
12 |
Zahra Heidari, Zahra Sharafi. Association of Non-Alcoholic Fatty Liver Dis-ease and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: a Cross-Sectional Study. Iranian South Medical Journal 2022; 25(1): 30 doi: 10.52547/ismj.25.1.30
|
13 |
Huiqi Yuan, Bin Zhu, Cao Li, Zhigang Zhao. Ceramide in cerebrovascular diseases. Frontiers in Cellular Neuroscience 2023; 17 doi: 10.3389/fncel.2023.1191609
|
14 |
Di Su, Ran Zhang, Xin Wang, Qi Ding, Feida Che, Wen Zhang, Wei Wu, Ping Li, Bo Tang. A new multi-parameter imaging platform for in vivo drug efficacy evaluation of ischemic stroke. Talanta 2024; 266: 125133 doi: 10.1016/j.talanta.2023.125133
|
15 |
Ahmed Arafa, Yoshihiro Kokubo, Rena Kashima, Chisa Matsumoto, Masatoshi Koga. Liver Enzymes and the Risk of Stroke among the General Japanese Population: A Prospective Cohort Study. Cerebrovascular Diseases 2024; 53(3): 252 doi: 10.1159/000533654
|
16 |
Ping Li, Jie Huang, Donghao Geng, Peihua Liu, Zhaoxing Chu, Jianjun Zou, Guoping Yang, Li Liu. Semi-Mechanistic Modeling of HY-021068 Based on Irreversible Inhibition of Thromboxane Synthetase. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.588286
|
17 |
Zijian Dai, Yiyun Zhang, Yantong Meng, Siqi Li, Zhuoma Suonan, Yuge Sun, Junfu Ji, Qun Shen, Hao Zheng, Yong Xue. Targeted delivery of nutraceuticals derived from food for the treatment of obesity and its related complications. Food Chemistry 2023; 418: 135980 doi: 10.1016/j.foodchem.2023.135980
|
18 |
Meng Zhang, Li Li, Jing Chen, Bei Li, Yutao Zhan, Chuan Zhang. Presence of diabetic retinopathy is lower in type 2 diabetic patients with non-alcoholic fatty liver disease. Medicine 2019; 98(18): e15362 doi: 10.1097/MD.0000000000015362
|
19 |
Jian Huang, Wanlin Jin, Xiangjie Duan, Xiaozhu Liu, Tingting Shu, Li Fu, Jiewen Deng, Huaqiao Chen, Guojing Liu, Ying Jiang, Ziru Liu. Twenty-eight-day in-hospital mortality prediction for elderly patients with ischemic stroke in the intensive care unit: Interpretable machine learning models. Frontiers in Public Health 2023; 10 doi: 10.3389/fpubh.2022.1086339
|
20 |
A. Yu. Timakova, Yu. P. Skirdenko, M. A. Livzan, T. S. Krolevets, N. A. Nikolaev, A. V. Nelidova. Cardiovascular comorbidity in non-alcoholic fatty liver disease. Experimental and Clinical Gastroenterology 2020; (10): 88 doi: 10.31146/1682-8658-ecg-182-10-88-95
|
21 |
Dandan Song, Chengqian Li, Zhongchao Wang, Yuhang Zhao, Baoming Shen, Wenjuan Zhao. Association of non‐alcoholic fatty liver disease with diabetic retinopathy in type 2 diabetic patients: A meta‐analysis of observational studies. Journal of Diabetes Investigation 2021; 12(8): 1471 doi: 10.1111/jdi.13489
|
22 |
Carla Greco, Fabio Nascimbeni, Francesca Carubbi, Pietro Andreone, Manuela Simoni, Daniele Santi. Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Peripheral Diabetic Polyneuropathy: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2021; 10(19): 4466 doi: 10.3390/jcm10194466
|
23 |
Stefano Ballestri, Claudio Tana, Maria Di Girolamo, Maria Cristina Fontana, Mariano Capitelli, Amedeo Lonardo, Giorgio Cioni. Semi-Quantitative Ultrasonographic Evaluation of NAFLD. Current Pharmaceutical Design 2020; 26(32): 3915 doi: 10.2174/1381612826666200417142444
|
24 |
M. K. Srilekha, S. N. Deepa, N. R. Shanker, M. Priya. Human Fatty Liver Volume Measurement Device Using Nano Graphene Polyvinyl Sensor. IEEE Sensors Journal 2023; 23(20): 25390 doi: 10.1109/JSEN.2023.3308769
|
25 |
Anel Karisik, Vincent Bader, Kurt Moelgg, Lucie Buergi, Benjamin Dejakum, Silvia Komarek, Michael Thomas Eller, Thomas Toell, Lukas Mayer-Suess, Raimund Pechlaner, Julian Granna, Simon Sollereder, Sonja Rossi, Gudrun Schoenherr, Johann Willeit, Peter Willeit, Wilfried Lang, Stefan Kiechl, Michael Knoflach, Christian Boehme, Markus Anliker, Gregor Broessner, Julia Ferrari, Martin Furtner, Andrea Griesmacher, Ton Hanel, Viktoria Hasibeder, Katharina Kaltseis, Gerhard Klingenschmid, Theresa Köhler, Stefan Krebs, Florian Krismer, Clemens Lang, Christoph Mueller, Wolfgang Nachbauer, Anna Neuner, Anja Perfler, Thomas Porpaczy, Gerhard Rumpold, Christoph Schmidauer, Theresa Schneider, Lisa Seekircher, Uwe Siebert, Christine Span, Martin Sojer, Lydia Thiemann, Lena Tschiderer, Marlies Wichtl, Karin Willeit. Comorbidities associated with dysphagia after acute ischemic stroke. BMC Neurology 2024; 24(1) doi: 10.1186/s12883-024-03863-1
|
26 |
Pil Gyu Park, Jung Yoon Pyo, Sung Soo Ahn, Hyun Joon Choi, Jason Jungsik Song, Yong-Beom Park, Ji Hye Huh, Sang-Won Lee. Fatty Liver Index Independently Predicts All-Cause Mortality in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis but No Substantial Liver Disease. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.848121
|
27 |
Fang-An Lin, Lee-Ching Hwang, Meng-Ting Tsou, Wei-Hsin Huang. Incidence of Metabolic Syndrome and Its Risk Factors in Elderly with Nonalcoholic Fatty Liver Disease. Diabetes, Metabolic Syndrome and Obesity 2023; : 2835 doi: 10.2147/DMSO.S425651
|
28 |
Takahisa Mori, Kazuhiro Yoshioka, Yuhei Tanno. Non-alcoholic fatty liver disease frequency and associated factors at admission of acute stroke. Hepatology International 2022; 16(1): 81 doi: 10.1007/s12072-021-10253-z
|